Healthcare -
Biotechnology - NASDAQ - US
$ 12.7
-9.61 %
$ 83.3 M
Market Cap
-1.12
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Instil Bio, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 73.5 M |
| Operating Income | -73.5 M |
| Other Expenses | 594 K |
| Net Income | -74.1 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0.1 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0 | 4.8 | 6.0 | 2.8 | 0 | 20 K |
| Gross Profit | 0 | (4.8) | (6.0) | (2.8) | 0.1 | 20 K |
| OPERATING INCOME | ||||||
| Operating Expenses | 73.5 | 85.8 | 203.3 | 155.6 | 33.8 | 6.6 |
| Selling, General and Administrative Expenses | 44.2 | 42.8 | 62.2 | 48.3 | 14.4 | 2.6 |
| Research and Development Expenses | 10.0 | 43.0 | 141.1 | 107.3 | 19.4 | 4.0 |
| Operating Income | (73.5) | (90.5) | (226.5) | (155.6) | (33.6) | (6.6) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 9.0 | 5.2 | 1.9 | 0 | 0 | 0 |
| Total Other Income | (0.6) | (65.5) | 1.2 | (1.2) | (3.9) | 63 K |
| Pre-Tax Income | (74.1) | (156.1) | (225.2) | (156.8) | (37.6) | (6.5) |
| NET INCOME | ||||||
| Tax Provision | 0 | 0 | (2.1) | 39 K | 0.2 | 68 K |
| Net Income | (74.1) | (156.1) | (223.2) | (156.8) | (37.7) | (6.5) |
| EPS | 11.4 | 24 | 34.5 | 24.3 | 5.89 | 1.01 |